News & press

Learn about what's new in the world of medical communications, company news, and what we're doing to make health and science information more accessible to the world.

11/15/2023

Nucleus Global Announces a Streamlined Approach to Optimize Client Support

Nucleus Global has announced a new simplified branding structure that will see a global team of 900 plus experts empowered to better serve the healthcare community.
07/19/2022

Nucleus Global are winners of ‘Medical Affairs Agency of the Year’ at Communiqué 2022

Triple success across Inizio at the leading European Healthcare Communications Awards
06/30/2022

World-leading agencies join forces to create strategic scientific powerhouse, Inizio Medical

World-leading agencies join forces to create strategic scientific powerhouse, Inizio Medical
06/10/2022

Reflections on the MAPS EMEA 2022 Annual Meeting

Amanda Henkel, VP Strategy, Nucleus X Consulting (part of Nucleus Global) shares her thoughts on this year’s meeting.
04/20/2022

From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting

Nucleus Global’s Luis Perez shares his thoughts on this year’s meeting
04/04/2022

Double success for Nucleus Global at the PM Society Awards 2022

Nucleus Global agencies Clinical Thinking, Health Interactions, and Meditech Media awarded bronze in two categories at the 2022 awards
02/28/2022

Advancing Our Profession: Driving Leadership and Best Practices in Medical Communications

Key themes and highlights from the 2022 European Meeting of ISMPP
02/28/2022

Starting a career in Medical Communications

Experiences from the Nucleus Academy
02/28/2022

PM Society Awards 2022 finalists

Nucleus Global agencies Clinical Thinking, Health Interactions and Meditech Media are finalists in two categories in the 2022 awards
02/26/2022

Rare Disease Day – looking to the future with hope

On this year’s Rare Disease Day, Amanda Henkel, VP, Strategy, Nucleus X Consulting (part of Nucleus Global), reflects on recent advances in the rare disease setting.